Literature DB >> 11168994

Importance of oxidatively modified proteins in chronic renal failure.

B Descamps-Latscha1, V Witko-Sarsat.   

Abstract

Considerable evidence has accumulated that chronic uremia is associated with a multifactorial immunoinflammatory syndrome, which occurs early in the course of renal failure, is accentuated with the progression of uremia, and culminates in maintenance dialysis therapy. We previously described the presence of a circulating oxidized plasma protein named advanced oxidation protein products (AOPPs). Beyond evidence that AOPPs represent an exquisite marker of oxidative stress, their role(s) in the pathophysiology of chronic renal failure and dialysis-related complications might be of great importance. Regarding the mechanisms of generation of AOPP, we underscore the importance of the chlorinated oxidants, previously solely considered as microbicidal agents, in the generation of AOPP. Indeed, AOPPs appear to act as true inflammatory mediators since they are able to trigger the oxidative burst in neutrophils as well as in monocytes. Thus, it is hypothesized that the AOPPs, which arise from the reaction between chlorinated oxidants and plasma proteins, constitute a new molecular basis for the deleterious activity of oxidants, and they could be considered to be true mediators of the proinflammatory effect of oxidative stress in uremia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168994     DOI: 10.1046/j.1523-1755.2001.59780108.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  19 in total

1.  Fructose-1,6-bisphosphate and N-acetylcysteine attenuate the formation of advanced oxidation protein products, a new class of inflammatory mediators, in vitro.

Authors:  Guilherme Vargas Bochi; Vanessa Dorneles Torbitz; Lara Peruzzolo Cargnin; Manuela Borges Sangoi; Roberto Christ Vianna Santos; Patrícia Gomes; Rafael Noal Moresco
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

Review 2.  The Labile Side of Iron Supplementation in CKD.

Authors:  Itzchak Slotki; Zvi Ioav Cabantchik
Journal:  J Am Soc Nephrol       Date:  2015-05-21       Impact factor: 10.121

Review 3.  Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease.

Authors:  Daryl M Okamura; Jonathan Himmelfarb
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

Review 4.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

5.  Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a.

Authors:  M Marin-Kuan; V Ehrlich; T Delatour; C Cavin; B Schilter
Journal:  J Toxicol       Date:  2011-06-22

6.  Oxidative stress in hepatitis C infected end-stage renal disease subjects.

Authors:  Mehmet Horoz; Cengiz Bolukbas; Filiz F Bolukbas; Mehmet Aslan; Ahmet O Koylu; Sahbettin Selek; Ozcan Erel
Journal:  BMC Infect Dis       Date:  2006-07-14       Impact factor: 3.090

7.  Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases.

Authors:  Kohei Nagumo; Motohiko Tanaka; Victor Tuan Giam Chuang; Hiroko Setoyama; Hiroshi Watanabe; Naoyuki Yamada; Kazuyuki Kubota; Motoko Tanaka; Kazutaka Matsushita; Akira Yoshida; Hideaki Jinnouchi; Makoto Anraku; Daisuke Kadowaki; Yu Ishima; Yutaka Sasaki; Masaki Otagiri; Toru Maruyama
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors.

Authors:  Veronika Binder; Senka Ljubojevic; Johannes Haybaeck; Michael Holzer; Dalia El-Gamal; Rudolf Schicho; Burkert Pieske; Akos Heinemann; Gunther Marsche
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-14       Impact factor: 8.311

9.  How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients.

Authors:  Zorica M Dimitrijevic; Tatjana P Cvetkovic; Vidojko M Djordjevic; Dusica D Pavlovic; Nikola Z Stefanovic; Ivana R Stojanovic; Goran J Paunovic; Radmila M Velickovic-Radovanovic
Journal:  Int J Med Sci       Date:  2012-10-26       Impact factor: 3.738

10.  Serum oxidized albumin and cardiovascular mortality in normoalbuminemic hemodialysis patients: a cohort study.

Authors:  Paik Seong Lim; Yachung Jeng; Ming Ying Wu; Mei-Ann Pai; Tsai-Kun Wu; Chia-San Liu; Chan Hsu Chen; Yuan-Chuan Kuo; Shiaw-Wen Chien; Hung Ping Chen
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.